Our investments

Vexim

Vexim (Alternext: ALVXM), co-founded by Truffle Capital (Dr Philippe Pouletty) in 2006, is the French leader in orthopaedic cements. Vexim specialises in mini-invasive solutions to treat the causes and consequences of vertebral fractures. It has specifically developed the SpineJack® implant to repair vertebral fractures. Vexim has already treated thousands of patients successfully.

Vexim was listed on Alternext in May 2012.

Dr Philippe Pouletty and Antoine Pau are Board members.

www.vexim.com